<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03124303</url>
  </required_header>
  <id_info>
    <org_study_id>2015-0374</org_study_id>
    <secondary_id>A530900</secondary_id>
    <secondary_id>SMPH\ANESTHESIOLOGY</secondary_id>
    <secondary_id>1K23AG055700-01A1</secondary_id>
    <secondary_id>1R01AG063849-01</secondary_id>
    <secondary_id>Protocol Version 11/5/2021</secondary_id>
    <nct_id>NCT03124303</nct_id>
  </id_info>
  <brief_title>Interventions for Postoperative Delirium: Biomarker-3</brief_title>
  <acronym>IPOD-B3</acronym>
  <official_title>Interventions for Postoperative Delirium: Biomarker-3</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Wisconsin, Madison</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The IPOD-B3 study aims to characterize the relationship between premorbid brain activity and&#xD;
      postoperative delirium in patients undergoing major surgery. This is a expansion of the&#xD;
      NeuroVISION Bolt-On study, NCT01980511.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      9/8/21-- Deleted two Outcome Measures pending IRB approval.&#xD;
&#xD;
      11/5/21-- added outcome measures after IRB approval.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 13, 2017</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Functional Connectivity</measure>
    <time_frame>Pre-operative measure: Up to 4 weeks prior to surgery. Post-operative measure: Post-Operative days 1-4</time_frame>
    <description>Change from baseline functional connectivity at immediate postoperative period and association between delirium (CAM) and functional connectivity of the cingulate cortex</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inflammation</measure>
    <time_frame>Pre-operative measure: Up to 4 weeks prior to surgery. Post-operative measure: POD1-4</time_frame>
    <description>Assess the changes from preoperative to postoperative EEG associated with delirium and change in plasma IL-6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarkers</measure>
    <time_frame>Post-operative day 1 through 4</time_frame>
    <description>Identify biomarkers of delirium and neural damage through changes in circulating plasma proteins and molecules (through mass spectometry)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain measurements</measure>
    <time_frame>Preoperative MRI will occur up to 4-weeks prior to surgery. Delirium is followed postoperatively, days 1-4</time_frame>
    <description>Assess the association between preoperative white matter connectivity (DTI) and cortical thickness (derived from MRI) and postoperative delirium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long term cognition</measure>
    <time_frame>Pre-operative cognition measures will occur up to 4 weeks prior to surgery. Post-operative delirium measured on postoperative days 1-4. Long term post-operative cognition measured 1 year after surgery.</time_frame>
    <description>Examine the incidence of delirium with change in cognition from preoperatively to one-year postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long term cognition</measure>
    <time_frame>Pre-operative measure: Up to 4 weeks prior to surgery. Post-operative measure: Up to one year after surgery</time_frame>
    <description>Assess the impact of delirium, preoperative and postoperative imaging biomarkers with a change in long term cognition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline cognition, specific and global.</measure>
    <time_frame>Cognition is assessed preoperatively. Participants are followed for delirium on postoperative days 1-4</time_frame>
    <description>Examine the association between preoperative cognition using a neuropsychological battery, and postoperative delirium incidence.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarkers and brain measurements</measure>
    <time_frame>Pre-op measures: up to 4 weeks prior to surgery. Post-op measures: one year after surgery.</time_frame>
    <description>Assess the changes in cognition and biomarkers over one year with EEG changes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Representativeness of surgical population</measure>
    <time_frame>Pre-op MRI: up to 4 weeks prior to surgery.</time_frame>
    <description>Identify whether patients who consent to the MRI are reflective of the surgical population.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Genetics and delirium</measure>
    <time_frame>Pre-op blood collected up to 4 weeks prior to surgery. Post-operative delirium measured on postoperative days 1-4. Post-operative blood collected on postoperative days 1-4. Long term blood collected 90 days and 1 year after surgery.</time_frame>
    <description>Identify genetic and epigenetic changes associated with delirium and its pathogenesis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative amyloid beta deposition and delirium</measure>
    <time_frame>Post-operative delirium measured on postoperative days 1-4. PET imaging will occur 90 days after surgery.</time_frame>
    <description>Identify associations between delirium and amyloid beta deposition detected by Positron Emission Tomography at 90 days after surgery in sub-study IPOD-PET.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long term changes in amyloid beta deposition and delirium</measure>
    <time_frame>Pre-operative PET imaging will occur up to 4 weeks prior to surgery. Post-operative delirium measured on postoperative days 1-4. Post-operative PET imaging will occur 1 year after surgery.</time_frame>
    <description>Identify associations between delirium and amyloid beta deposition detected by Positron Emission Tomography preoperatively and 1 year after surgery in sub-study IPOD-PET2.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">310</enrollment>
  <condition>Delirium</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>High Density-Electroencephalogram</intervention_name>
    <description>EEG is a safe non-invasive technology without complications that may be used to help diagnose delirium</description>
    <other_name>EEG</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Magnetic Resonance Imaging</intervention_name>
    <description>MRI scan of brain</description>
    <other_name>MRI</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Participant blood will be collected and stored for future analysis.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients, 65 years of age and older, undergoing surgery with an estimated length of stay of&#xD;
        2 days or greater.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age â‰¥65 years&#xD;
&#xD;
          -  Anticipated length of hospital stay of at least 2 days after surgery that occurs under&#xD;
             general or neuraxial anesthesia&#xD;
&#xD;
          -  Written Informed Consent for potential participation prior to surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindication to MRI or EEG (e.g. implanted devices not safe for MRI studies,&#xD;
             claustrophobia, unable to lie flat or still),&#xD;
&#xD;
          -  Unable or unwilling to attend the follow-up appointments,&#xD;
&#xD;
          -  Documented history of dementia&#xD;
&#xD;
          -  Residing in a nursing home,&#xD;
&#xD;
          -  Undergoing intracranial surgery&#xD;
&#xD;
          -  Unable to complete neurocognitive testing due to language, vision or hearing&#xD;
             impairment,&#xD;
&#xD;
          -  Unable to communicate with the research staff due to language barriers,&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Pearce, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Wisconsin, Madison</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maggie Parker, BS</last_name>
    <phone>608-262-6469</phone>
    <email>parker8@wisc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>David Kunkel, BS</last_name>
    <phone>608-262-6469</phone>
    <email>dkunkel@wisc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Wisconsin-Madison</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maggie Parker</last_name>
      <phone>608-262-6469</phone>
      <email>parker8@wisc.edu</email>
    </contact>
    <contact_backup>
      <last_name>David Kunkel</last_name>
      <phone>608-262-6469</phone>
      <email>dkunkel@wisc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Robert Pearce, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>March 29, 2017</study_first_submitted>
  <study_first_submitted_qc>April 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2017</study_first_posted>
  <last_update_submitted>November 12, 2021</last_update_submitted>
  <last_update_submitted_qc>November 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

